A multicenter clinical study to evaluate the efficacy and feasibility of a 24-week multidomain intervention via a none-face-to-face platform in mild cognitive impairment

Inha University Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新: 2022年5月2日

适应症

试验速览

暂无简介。

•1. Subjects who completed end-of-study evaluation and participated in the preceding randomized controlled trial (RCT) Multidomain Interventions Via Face-to-face and Video Communication Platforms in Mild Cognitive Impairment.
•2. Being able to use the tablet PC through education, or having a person who can help a participant use the tablet PC.
•3. Having a reliable informant who could provide investigators with the requested information
•4. Provide written informed consent

•1. Major psychiatric illness such as major depressive disorders
•2. Dementia
•3. Other neurodegenerative disease (e.g., Parkinson's disease)
•4. Malignancy within 5 years
•5. Cardiac stent or revascularization within 1 year
•6. Serious or unstable symptomatic cardiovascular disease
•7. Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease
•8. Severe loss of vision, hearing, or communicative disability
•9. Any conditions preventing cooperation as judged by the study physician
•10. Significant laboratory abnormality that may result in cognitive impairment
•11. Illiteracy
•12. Unable to participate in exercise program safely
•13. Coincident participation in any other intervention trial

发起方